Chemical | 31 May 2021
Robust performance of Balaji Amines: HDFC Securities
The new plant of ethylamines at Solapur has commenced operations from May'21
The new plant of ethylamines at Solapur has commenced operations from May'21
Targeted Spraying Technology can provide a significant reduction in herbicide use in growing crops and fallow ground, as well as night and day applications
Contract is for six years duration and covers Project Engineering and Management Services for various potential projects in the Al-Zour complex
With BASF’s simulation tool Ultrasim, the part behavior can be accurately predicted subject to various loading and environmental conditions.
Equinor and Polenergia are currently jointly developing the Ba?tyk III, Ba?tyk II and Ba?tyk I offshore wind projects.
The assets to be acquired are located in Dallas, Texas, USA witha combined capacity of approx. 92 kilotons per annum, consisting of 48 kilotons of rPET pelletsand 44 kilotons of flakes.
The company will continue its growth and develops itself as a broad energy company within the framework of an integrated strategy around four areas
Company aims to increase its share of emissions based on renewable biogenic sources to 40% by 2030
The project will showcase Linde’s post-combustion CO2 capture technology capabilities
MCC will be able to accelerate its undertakings by expanding its processing technologies through this recent acquisition of shares in Nakai Industrial
The new agreement will see Biesterfeld marketing the products throughout Europe, except Italy, and in some neighbouring countries in Africa and the Middle East
BPCL expects to close the acquisition of Oman Oil's 36.32% stake in BORL for a consideration of Rs24bn by June 15 this year
India formulations business grew 14.7% YoY with recovery in industry growth from COVID-19 impact
Acquisition of one of China’s leading crop protection producers, bolstering ADAMA’s operations in China and its global product offering
US revenues were sequentially stable at US$370mn with steady performance in the specialty portfolio
Cadila's ZyCov-D (DNA-based vaccine) is undergoing phase III trials.
The company reported total income of Rs.24774.63 crores during the 12 months period ended March 31, 2021
It reported total income of Rs.1452.14 crores during the 12 months period ended March 31, 2021
The company has posted net profit of Rs.56.39 crores in FY2020-21
Creating a system to supply high-performance polypropylene and bolstering circular economy-related efforts
Subscribe to our newsletter & stay updated.
